Jyothy Labs share news, announcements and annual reports
NSE: JYOTHYLABBSE: 532926Household ProductsSmall Cap
Jyothy Labs Limited · Formerly Jyothy Laboratories · Face value ₹1 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Dec 2007
Last close ₹171.91down ₹3.15 (1.80%)BSE ₹172.05
Share price at the NSE close on 30 Oct 2026. Previous close ₹175.06.
30 Oct: open ₹174.45, high ₹175.10, low ₹171.00
52-week range of traded prices to 30 Oct 2026
₹171.00Low, 30 Oct 2026₹322.75High, 30 Oct 2025
- Next results date: the board meets on 4 Nov 2026 to consider: financial results and buyback. The notice · Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹6,313 Cr603rd largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 22.23
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 3.97
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 2.04%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 19.1%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 20.6%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.00
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 1,85,76453.8% delivered
Jyothy Labs share news and announcements
834 announcements, routine notices left out, newest first. Page 14 of 17.
Jan 2016
Nov 2015
Oct 2015
Sep 2015
4 Sep · News Verification
News about Jyothy Laboratories Limited.The media had reports that "Henkel Plans India Return with 26% in Jyothy Labs".The Exchange, in order to verify the accuracy or otherwise of the information reported in the media and to inform the market place so that the interest of the investors is safeguarded, had written to the company.Jyothy Laboratories Limited has vide its letter inter-alia stated, "We would like to inform you that as per our letter dated May 5, 2011 to the exchanges, Henkel AG has an option to acquire upto 26% of equity share capital of Jyothy Laboratories Limited through primary and / or secondary transactions, after a period of 5 (five) years, subject to the terms and conditions to be mutually agreed. They have an option which they can exercise between April 1, 2016 and March 31, 2017.The article incorrectly mentions that the deadline for the same is March 31, 2016. As of now there is no development in this regard and the report is speculative. In case there is any development, we shall inform the exchanges."4 Sep · News Verification
Exchange has sought clarification from Jyothy Laboratories Limited, with respect to recent news item captioned "Henkel Plans India Return with 26% in Jyothy Labs". In this regard, the Exchange has advised the Company to provide clarification/confirmation on the news item in detail including the following: a) Whether such negotiations were taking place and b) Whether you/company are aware of any information that has not been announced to the Exchanges which could explain the aforesaid movement in the trading. The response from the company is awaited.
Aug 2015
3 Aug · Disclosure of Voting Pattern - Clause 35A
Jul 2015
6 Jul · Meeting
Register of Members and the Share Transfer Books of the Company will remain closed from July 17, 2015 to July 30, 2015 (both days inclusive) for the purpose of Annual General Meeting (AGM) and to ascertain the names of Members who will be entitled to receive dividend on the equity shares of the company for the financial year ended March 31, 2015, if approved at the ensuing Annual General Meeting. Further the Annual General Meeting of the members of the Company will be held on July 30 , 2015.
May 2015
Apr 2015
Jan 2015
Dec 2014
Nov 2014
Oct 2014
20 Oct · Board meeting
Inter-alia to consider the Un-Audited Standalone and Consolidated Financial Results of the Company for the 2nd quarter and half year ended September 30, 2014.
Aug 2014
28 Aug · Disclosure
Remuneration and Compensation Committee of the Board of Directors of the Company at its meeting held on August 16, 2014 has approved the grant of 5,03,445 Stock Options to eligible employees of the Company, in terms of Employee Stock Option Scheme 2014 ("ESOS-2014"). The said options carry the right to apply for equivalent number of equity shares of the Company of face value of Re. 1/- each, the brief terms of which are as under: 1. Vesting : The options shall vest over a period of 4 years on the basis of time and performance. 2. exercise period 5 years from the date of vesting of options. 3. Exercise price Re. 1/- per share for 5,03,445 of stock options.28 Aug · Disclosure
Remuneration and Compensation Committee of the Board of Directors of the Company at its meeting held on August 16, 2014 has approved the grant of 27,15,325 Stock Options to Mr.S Raghunandan, Whole Time Director and CEO of the Company, in terms of Employee Stock Option Scheme 2014-A ("ESOS-2014-A"). The said options carry the right to apply for equivalent number of equity shares of the Company of face value of Re. 1/- each, the brief terms of which are as under: 1. Vesting : The options shall vest over a period of 4 years on the basis of time and performance. 2. exercise period 5 years from the date of vesting of options. 3. Exercise price Re. 1/- per share for 27,15,352 of stock options.21 Aug · Updates
1) Mr. K .Ullas Kamath, Joint Managing Director of the Company has also been entrusted with the additional responsibility of Chief Financial Officer of the Company. 2) Consequent to Appointment of Mr. K Ullas Kamath as Chief Financial Officer, Mr. M L Bansal will be Company Secretary & Compliance Officer of the Company.18 Aug · Disclosure of Voting Pattern - Clause 35A
Jul 2014
18 Jul · Meeting
Register of Members and the Share Transfer Books of the Company will remain closed from August 02, 2014 to August 13, 2014 (both days inclusive) in connection with the ensuing Annual General Meeting (AGM) of the Company scheduled to be held on August 13, 2014 as well as for payment of dividend that may be declared / approved at the ensuing AGM.18 Jul · Board meeting
To consider inter-alia the Un-Audited Financial Results of the Company for the 1st Quarter ended June 30, 2014.
May 2014
22 May · Board meeting
Board of Directors of the Company at its meeting held on May 22, 2014 has transacted the following: (1) Approved, subject to approval of shareholders, the constitution of Employee Stock Option Schemes to create, offer and grant Stock Options to CEO & other permanent employees of the Company and matters connected therewith. (2) Approved extension of the tenure of Mr. S. Raghunandan - Whole Time Director and CEO of the Company by two years i.e. from May 23, 2015 to May 22, 2017.22 May · Dividend
Board of Directors of the Company at its meeting held on May 22, 2014 has Recommended Final Dividend of Rs. 2.00 (Rupees Two Only) per equity share of Re. 1/- each for the financial year ended March 31, 2014. The payment of dividend is subject to approval of shareholders at the ensuing Annual General Meeting.